{"DataElement":{"publicId":"3436556","version":"1","preferredName":"Prostate Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage","preferredDefinition":"Extent of the primary prostate carcinoma based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"2188756v1.0:3436508v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188756","version":"1","preferredName":"Prostate Tumor Clinical T","preferredDefinition":"Information related to clinical T stage of a prostate tumor.","longName":"PRS_TUMOR_C_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E552D669-7D8C-67B3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-30","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt changed Reg Station and released. 9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3436508","version":"1","preferredName":"Prostate Cancer American Joint Committee on Cancer Edition 7 Clinical T Stage","preferredDefinition":"A clinical finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3436508v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4","valueDescription":"Prostate Cancer cT4 TNM Finding v7","ValueMeaning":{"publicId":"3436509","version":"1","preferredName":"Prostate Cancer cT4 TNM Finding v7","longName":"3436509","preferredDefinition":"Prostate cancer with fixed tumor or tumor invading adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT4 TNM Finding v7","conceptCode":"C89221","definition":"Prostate cancer with fixed tumor or tumor invading adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-4585-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-459E-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Prostate Cancer cT3b TNM Finding v7","ValueMeaning":{"publicId":"3351743","version":"1","preferredName":"Prostate Cancer cT3b TNM Finding v7","longName":"3351743","preferredDefinition":"Prostate cancer invading seminal vesicle(s). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT3b TNM Finding v7","conceptCode":"C89220","definition":"Prostate cancer invading seminal vesicle(s). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65D74EE-036A-8145-E040-BB89AD435B9F","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-45B2-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Prostate Cancer cT3a TNM Finding v7","ValueMeaning":{"publicId":"3351745","version":"1","preferredName":"Prostate Cancer cT3a TNM Finding v7","longName":"3351745","preferredDefinition":"Prostate cancer with extracapsular extension (unilateral or bilateral). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT3a TNM Finding v7","conceptCode":"C89219","definition":"Prostate cancer with extracapsular extension (unilateral or bilateral). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65D74EE-0390-8145-E040-BB89AD435B9F","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-45C7-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T3","valueDescription":"Prostate Cancer cT3 TNM Finding v7","ValueMeaning":{"publicId":"3436510","version":"1","preferredName":"Prostate Cancer cT3 TNM Finding v7","longName":"3436510","preferredDefinition":"Prostate cancer extending through the prostatic capsule.  Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is classified not as T3 but as T2. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT3 TNM Finding v7","conceptCode":"C89218","definition":"Prostate cancer extending through the prostatic capsule.  Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is classified not as T3 but as T2. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-45D2-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-45EB-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T2c","valueDescription":"Prostate Cancer cT2c TNM Finding v7","ValueMeaning":{"publicId":"3351735","version":"1","preferredName":"Prostate Cancer cT2c TNM Finding v7","longName":"3351735","preferredDefinition":"Prostate cancer with tumor involving both lobes. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT2c TNM Finding v7","conceptCode":"C89217","definition":"Prostate cancer with tumor involving both lobes. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65D74EE-02C2-8145-E040-BB89AD435B9F","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-45FF-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T2b","valueDescription":"Prostate Cancer cT2b TNM Finding v7","ValueMeaning":{"publicId":"3351737","version":"1","preferredName":"Prostate Cancer cT2b TNM Finding v7","longName":"3351737","preferredDefinition":"Prostate cancer with tumor involving more than one-half of one lobe, but not both lobes. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT2b TNM Finding v7","conceptCode":"C89216","definition":"Prostate cancer with tumor involving more than one-half of one lobe, but not both lobes. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65D74EE-02E8-8145-E040-BB89AD435B9F","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-4614-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T2a","valueDescription":"Prostate Cancer cT2a TNM Finding v7","ValueMeaning":{"publicId":"3351739","version":"1","preferredName":"Prostate Cancer cT2a TNM Finding v7","longName":"3351739","preferredDefinition":"Prostate cancer with tumor involving one-half of one lobe or less. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT2a TNM Finding v7","conceptCode":"C89215","definition":"Prostate cancer with tumor involving one-half of one lobe or less. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65D74EE-030E-8145-E040-BB89AD435B9F","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-4629-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T2","valueDescription":"Prostate Cancer cT2 TNM Finding v7","ValueMeaning":{"publicId":"3436511","version":"1","preferredName":"Prostate Cancer cT2 TNM Finding v7","longName":"3436511","preferredDefinition":"Prostate cancer confined within the prostate.  Tumor found in one or both lobes by needle biopsy, but not palpable or reliably visible by imaging, is classified as T1c. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT2 TNM Finding v7","conceptCode":"C89214","definition":"Prostate cancer confined within the prostate.  Tumor found in one or both lobes by needle biopsy, but not palpable or reliably visible by imaging, is classified as T1c. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-4634-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-464D-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T1c","valueDescription":"Prostate Cancer cT1c TNM Finding v7","ValueMeaning":{"publicId":"3351724","version":"1","preferredName":"Prostate Cancer cT1c TNM Finding v7","longName":"3351724","preferredDefinition":"Tumor identified by needle biopsy (e.g., because of elevated PSA). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT1c TNM Finding v7","conceptCode":"C89213","definition":"Tumor identified by needle biopsy (e.g., because of elevated PSA). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65BB4F3-5FDB-218B-E040-BB89AD4337DD","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-4661-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Prostate Cancer cT1b TNM Finding v7","ValueMeaning":{"publicId":"3351726","version":"1","preferredName":"Prostate Cancer cT1b TNM Finding v7","longName":"3351726","preferredDefinition":"Tumor incidental histologic finding in more than 5% of tissue resected. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT1b TNM Finding v7","conceptCode":"C89212","definition":"Tumor incidental histologic finding in more than 5% of tissue resected. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65BB4F3-6001-218B-E040-BB89AD4337DD","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-4676-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Prostate Cancer cT1a TNM Finding v7","ValueMeaning":{"publicId":"3351728","version":"1","preferredName":"Prostate Cancer cT1a TNM Finding v7","longName":"3351728","preferredDefinition":"Tumor incidental histologic finding in 5% or less of tissue resected. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT1a TNM Finding v7","conceptCode":"C89211","definition":"Tumor incidental histologic finding in 5% or less of tissue resected. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65BB4F3-6027-218B-E040-BB89AD4337DD","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-468B-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T1","valueDescription":"Prostate Cancer cT1 TNM Finding v7","ValueMeaning":{"publicId":"3436512","version":"1","preferredName":"Prostate Cancer cT1 TNM Finding v7","longName":"3436512","preferredDefinition":"Clinically inapparent tumor neither palpable nor visible by imaging. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT1 TNM Finding v7","conceptCode":"C89210","definition":"Clinically inapparent tumor neither palpable nor visible by imaging. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-4696-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-46AF-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"T0","valueDescription":"Prostate Cancer cT0 TNM Finding v7","ValueMeaning":{"publicId":"3436514","version":"1","preferredName":"Prostate Cancer cT0 TNM Finding v7","longName":"3436514","preferredDefinition":"No evidence of primary tumor. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cT0 TNM Finding v7","conceptCode":"C89209","definition":"No evidence of primary tumor. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-46BC-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-46D5-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"TX","valueDescription":"Prostate Cancer cTX TNM Finding v7","ValueMeaning":{"publicId":"3351730","version":"1","preferredName":"Prostate Cancer cTX TNM Finding v7","longName":"3351730","preferredDefinition":"Primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cTX TNM Finding v7","conceptCode":"C89208","definition":"Primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65BB4F3-604D-218B-E040-BB89AD4337DD","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-46E9-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3436507","version":"1","preferredName":"Prostate Cancer Clinical TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A clinical finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89206:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer Clinical TNM Finding v7","conceptCode":"C89206","definition":"A clinical finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-455C-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-456D-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000013","version":"1","longName":"Prostate","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855643","version":"1","longName":"Prostate Pathology","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000014","version":"1","longName":"Prostate","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000595","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PROST_CLIN_T_STAGE","type":"Context Short Name","context":"NRG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"ajcc_7_prostate_clinical_t","type":"MCL Alt Name","context":"MCL"},{"name":"RS_RSORRES_TSTAGE","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"NCI Standards"},{"name":"MCL Path-1","type":"Alternate Question Text","description":"Clinical Stage - T","url":null,"context":"MCL"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Clinical T-stage","url":null,"context":"Theradex"},{"name":"MCL-PCA-prostate-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer clinical primary tumor T stage","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BD6E0AEC-94BA-FD5E-E040-BB89AD435193","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeDescription":"9/22/21 mr Added alt name, AQT, alt def, ref doc, CSI for MCL PCA prostate. Per MCL DD.   Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":"11/16/23 Added alt OID for CCTG ticket number CADSR0003085 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}